Latest stories on QURE
uniQure stock upgraded by Wolfe Research on Huntington’s therapy outlook
Investing.com Analyst Ratings61 · neutralanalyst
UniQure outlines AMT-130 BLA this quarter, supported by cash runway into 2030
Seeking Alpha67 · bullishproduct/pr
uniQure N.V. (QURE) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
uniQure’s Strong Cash Position Supports Accelerated Pipeline Progress Heading Into AMT-130 Regulatory Milestones
July 29, 2026
MarketChameleon67 · bullishproduct/pr
UniQure reports Q2 revenue beat, extends cash runway to 2030
Investing.com Markets63 · neutralearnings
uniQure GAAP EPS of -$1.22 misses by $0.42, revenue of $5.84M beats by $0.46M
Seeking Alpha46 · neutralearnings
uniQure N.V. (QURE) files 8-K
SEC 8-K50 · neutralgeneral
uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
Business Insider56 · neutralearnings
uniQure Q2 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
uniQure to Announce Second Quarter 2026 Financial Results
Business Insider50 · neutralgeneral
uniQure to Announce Second Quarter 2026 Financial Results | QURE Stock News
StockTitan50 · neutralgeneral
Warden Capital Q2 2026 Letter
Seeking Alpha73 · bullishgeneral
UniQure N.V. (QURE) Upgraded to Overweight as Huntington’s Disease Program Advances
Yahoo Top61 · neutralanalyst
uniQure Completes Upsized Public Equity Offering for Growth
TipRanks24 · bearishgeneral
uniQure N.V. (QURE) files 8-K
SEC 8-K50 · neutralgeneral
uniQure Announces Pricing of Upsized $225 Million Public Offering | QURE Stock News
StockTitan24 · bearishgeneral
uniQure files $150M proposed public offering of ordinary shares
Seeking Alpha24 · bearishgeneral
uniQure Announces $150 Million Proposed Public Offering | QURE Stock News
StockTitan24 · bearishgeneral
uniQure Announces Promising Early Data for AMT-260
TipRanks67 · bullishproduct/pr
uniQure N.V. (QURE) files 8-K
SEC 8-K50 · neutralgeneral
uniQure Stock Looks Drastically Undervalued After Upbeat FDA Meeting
Barchart63 · neutralgeneral
UniQure: AMT-130's FDA Path Reaffirms My Bull Case
Seeking Alpha73 · bullishproduct/pr
UniQure (QURE) Soars 78% on AMT-130 Progress
Yahoo Finance86 · bullishproduct/pr